CAPGET

Capecitabine is a prodrug which metabolizes in higher concentrations in tumour cells to the active drug 5-Fluorouracil (5-FU).

Capecitabine is a prodrug which metabolizes in higher concentrations in tumour cells to the active drug 5-Fluorouracil (5-FU). This is because an enzyme, thymidine phosphorylase, required in the last step of conversion to 5-FU is present in higher concentrations in certain cancer cells of breast, colon and rectum. The upregulation of thymidine phosphorylase by docetaxel makes it a synergistic combination with capecitabine. Capecitabine provides a valuable option in patients of metastatic breast cancer who are resisitant to anthracycline and paclitaxel-containing regimens or those for whom anthracyclines are contraindicated.

Indications:

  • Metastatic colorectal cancer as 1st line therapy
  • Locally advanced or metastatic breast cancer after failure of a taxane and an anthracycline-containing regimen

 

Generic Name

Strength

Standard

Type

Packing

Pack Size

Capecitabine

150 mg

IHS

Tablets

Strip

10

Capecitabine

500 mg

IHS

Tablets

Strip

10